Zolpidem Tartrate Tablet, Film Coated, Extended Release
Product Images NDC 71610-254

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71610-254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 12.5 mg (71610 0254 30)

Zolpidem Tartrate Ex, USP is a medication available in tablet form with a strength of 12.5 mg or 30 mg per tablet. The manufacturer is based in India. No further information is available due to the low quality of .*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure1 (Figure1)

The text describes a figure showing the mean plasma concentration-time profiles for two types of Zolpidem Tartrate tablets: the 12.5 mg extended-release tablets and the 10 mg immediate-release tablets. The figure includes a graph with the vertical axis representing plasma concentrations in ng/mL and the horizontal axis representing time. The graph shows that the extended-release tablets maintain higher plasma concentrations for a longer period compared to the immediate-release tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.